Heart disease is still the leading cause of death for women.
And yet, for years, the conversation around prevention has missed one critical piece: hormones.
Recent guidance from The Menopause Society is bringing that connection back into focus — and it’s changing how we think about risk during midlife.
What changes during menopause
As estrogen levels decline, the protective effect it once had on your cardiovascular system begins to fade. Blood vessels become less flexible. Cholesterol patterns shift. Inflammation can increase.
This isn’t sudden — it’s gradual. And often, it’s silent.
Many women who have never had a heart concern before menopause begin to see changes in blood pressure, cholesterol, and overall cardiovascular risk.
Why timing matters
One of the most important insights from recent research is this: timing matters when it comes to hormone therapy.
When started in the right window — early in menopause — hormone therapy may support heart health rather than harm it for appropriate candidates.
But this is nuanced. It depends on your personal history, your risk factors, and your symptoms.
This is not a one-size-fits-all decision.
What this means for you
If you are in your 40s or 50s and starting to notice shifts — fatigue, weight changes, sleep disruption, or new cardiovascular markers — it’s worth looking at the full picture.
Not just your labs.
Not just your symptoms.
But how they connect.
This is exactly how we approach care at Charleston House. We don’t separate hormone health from heart health — because your body doesn’t separate them.
If you’ve been wondering what menopause means for your long-term health, this is the conversation to have now — not later.